ArticleJournal of experimental & clinical cancer research : CR2023

Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer.

Nar Bahadur Katuwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.